Novel saitohin gene and uses of same
AssigneeAlbert Einstein College of Medicine of Yeshiva University
InventorsChris Conrad, Peter Davies
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlbert Einstein College of Medicine of Yeshiva University
InventorsChris Conrad, Peter Davies
Estimating the term…
The present invention provides an isolated nucleic acid sequence encoding saitohin (STH), an isolated nucleic acid sequence that hybridizes to said sequence, and a purified protein encoded by said nucleic acid sequences. The present invention also provides a purified STH protein, and a method of making STH protein. The present invention is further directed to an antibody specific for STH, and a method for producing said antibody. Additionally, the present invention discloses a vector comprising a nucleic acid sequence encoding STH, a host cell transformed with said vector, and transgenic nonhuman animals. The present invention further provides methods for determining whether a subject has, or is at increased risk for developing, a neurodegenerative disease, and for assessing said subject's prognosis. Finally, the present invention discloses kits for determining whether a subject has, or is at increased risk for developing, a neurodegenerative disease.
1-19. (canceled)
An antibody specific for saitohin (STH) protein.
A method for producing an antibody specific for saitohin (STH) protein, comprising the steps of:
27-59. (canceled)
Dependencies are inferred from the claim text.